Condition: OCD · Sponsor: University of Pennsylvania
Studies show that hormones affect the brain's fear extinction network, which is relevant for therapy involving exposure and response prevention (EX/RP), a first-line treatment for obsessive compulsive disorder (OCD). This study will examine the effect of delivering EX/RP to women during different phases in their menstrual cycle to determine the effects of hormones on the fear extinction network and on their OCD symptoms.
This description comes directly from the study's public registry record.
Bryanna Mackey · 2157463344 · Bryanna.Mackey@Pennmedicine.upenn.edu
Sara Rose Shannon, BS, MS · 6467748082 · SaraRose.Shannon@nyspi.columbia.edu
Always discuss trial participation with your own doctor first.
| New York State Psychiatric Institute | New York, New York, United States | Recruiting |
| University of Pennsylvania | Philadelphia, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05359562